Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Shiyam Kumar"'
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 234-242 (2023)
Tubulocystic carcinoma of the kidney (TC-RCC) is a rare renal tumor and has been recently included as a distinct entity in WHO classification of renal neoplasms. We report the case of a patient with metastatic tubulocystic RCC whose disease progresse
Externí odkaz:
https://doaj.org/article/0eecd37fd61c4170acd5a9bcde1eb3d7
Autor:
Safia Al Nabhani, Athra Al Harthy, Marwa Al Riyami, Shadia Al Sinawi, Afrah Al Rashdi, Samiya Al Husseni, Shiyam Kumar
Publikováno v:
Oman Medical Journal, Vol 37, Iss 6, Pp e441-e441 (2022)
Objectives: To evaluate the expression of programmed death-ligand 1 (PD-L1) in bladder cancer cases in Oman using immunohistochemistry, and to determine whether the level of PD-L1 expression is associated with tumor grade, stage, or outcome. An addit
Externí odkaz:
https://doaj.org/article/c144e36db27946309facd7f97dae44ea
Autor:
Shiyam Kumar, Ikram A. Burney, Joseph Kunju, Mohammed Salim Al-Marhoon, Khurrum Mutahir Siddiqui
Publikováno v:
Oman Medical Journal, Vol 37, Iss 1, Pp e333-e333 (2022)
Objectives: Prostate cancer (PCa) is the third most common cancer worldwide, with its incidence rising in the Middle East. There is a paucity of data about the clinicopathological features and outcomes of metastatic prostate cancer (mPCa) from the Mi
Externí odkaz:
https://doaj.org/article/1efc3685c5a643c394728f9c2d5b2134
Autor:
Shiyam Kumar, Muhammad Furrukh, Khalid Al-Baimani, Adil Al-Ajmi, Ikram A. Burney, Mansour S. Al-Moundhri
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 19, Iss 3, Pp 209-216 (2019)
Objectives: Triple-negative breast cancer (TNBC) is one of the most aggressive and heterogeneous variants of breast cancer. However, little is known regarding the prevalence and outcome of this entity in the Middle East. This study aimed to evaluate
Externí odkaz:
https://doaj.org/article/1174e3480ac145f4960bed71364cb777
Autor:
Khawaja F. Zahid, Shiyam Kumar, Khalid Al-Bimani, Tanweer Ahmed, Adil Al-Ajmi, Ikram A. Burney, Mansour Al-Moundhri
Publikováno v:
Oman Medical Journal, Vol 34, Iss 5, Pp 412-419 (2019)
Objectives: Breast cancer (BC) is the leading cancer among women. Almost 20% of patients develop brain metastases (BM) and die shortly afterward. There is a dearth of data on the survival outcome of BC patients with BM from the Arab world. Methods: C
Externí odkaz:
https://doaj.org/article/29920a64c2284cc9a0ed16409a7b2dab
Publikováno v:
Oman Medical Journal, Vol 33, Iss 6, Pp 527-530 (2018)
Choriocarcinoma of the ovary is a rare neoplasm and tends to metastasize early to involve the lungs, brain, and liver. Metastasis to the gastrointestinal tract is rare. We report the case of a young lady, who presented with life-threatening gastroint
Externí odkaz:
https://doaj.org/article/d7e5bff2eefc4eaf9017410bdae0a6a5
Autor:
Muhammad Furrukh, Shiyam Kumar, Khawaja F. Zahid, Hanan S. Al-Shamly, Zainab A. Al-Jabri, Ikram A. Burney, Mansour S. Al-Moundhri
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 17, Iss 3, Pp 301-308 (2017)
Objectives: The incidence of lung cancer in Oman has shown a gradual but definitive increase since 2002. This study aimed to evaluate the demographic and epidemiological characteristics and survival outcomes of patients with non-small-cell lung cance
Externí odkaz:
https://doaj.org/article/6d30a8c04fea4d05961694d2598c3f7e
Publikováno v:
Asia-Pacific Journal of Oncology Nursing, Vol 4, Iss 4, Pp 323-329 (2017)
The epidermal growth factor receptor (EGFR) is actively involved in the growth of multiple tumor types and has been found as an effective treatment target in various solid cancers, for example, lung cancer and head and neck cancer. Of effective drugs
Externí odkaz:
https://doaj.org/article/d7e86984715d41d3bba77181223f4394
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 13, Iss 2, Pp 202-217 (2013)
A series of phase II and randomised phase III trials in Asia and Europe have confirmed recently that advanced stage non-small-cell lung carcinoma patients with adenocarcinoma subtypes harbouring specific mutations when subjected to targeted therapy e
Externí odkaz:
https://doaj.org/article/1cf3fa3f8e6f4a9ab10ca5041af50704
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 13, Iss 1, Pp 3-18 (2013)
Systemic chemotherapy has remained the traditional treatment for metastatic non-small-cell lung carcinoma (NSCLC), enhancing survival rate at 1 year to 29%. The median survival had plateaued at around 10 months until early 2008, and in an attempt to
Externí odkaz:
https://doaj.org/article/7d422592caf24274a72ae62935694c5a